CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

BIOTRONIK Neuro Launches Embrace One® Proactive Intelligence, a Proprietary AI Capability that Identifies Emerging Support Needs in SCS Patients

ConferencepositiveEmbrace One® Proactive IntelligencePositive
AI Analysis

Summary

BIOTRONIK Neuro announced the launch of Embrace One® Proactive Intelligence, an AI capability for identifying emerging support needs in spinal cord stimulation patients. Data presented at ASPN demonstrated the model's ability to identify patients requiring support before they recognize problems themselves.

Outcome Details

AI model demonstrated ability to identify patients who may benefit from support, often before patients recognize problems themselves

Importance:5/10
Sentiment:
0.60
artificial intelligencespinal cord stimulationASPN conferencepatient supportmedical device

Read the original article

Published by PR Newswire Clinical Trials on July 20, 2026 12:41 PM

Read Original